---
title: "Eagle Pharma sells Barhemsys (amisulpride) rights in U.S. to LXO Group, Paris, under OTCMKTS: EGRX, effective Jan. 14, 2026."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/272577751.md"
description: "Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) has announced the sale of its U.S. marketing rights for Barhemsys (amisulpride) to LXO Group, based in Paris, effective January 14, 2026. This decision reflects Eagle's strategy to concentrate on its core operations and growth initiatives. Financial details of the transaction were not disclosed, marking a significant development for both companies involved."
datetime: "2026-01-14T15:22:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272577751.md)
  - [en](https://longbridge.com/en/news/272577751.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272577751.md)
---

# Eagle Pharma sells Barhemsys (amisulpride) rights in U.S. to LXO Group, Paris, under OTCMKTS: EGRX, effective Jan. 14, 2026.

Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) based in Woodcliff Lake, N.J., disclosed today its decision to divest the marketing authorization for Barhemsys (amisulpride) in the U.S. The Company will transfer this authorization to LXO Group, headquartered in Paris, France. This strategic move signifies Eagle's focus on its core operations and expansion plans. The specifics of the deal, including financial terms and duration, were not publicly disclosed. The transaction is part of Eagle's larger business strategy and marks a significant development for both companies involved.

### Related Stocks

- [EGRX.US](https://longbridge.com/en/quote/EGRX.US.md)

## Related News & Research

- [Viridien: 2026 first-quarter results | CGG Stock News](https://longbridge.com/en/news/285234459.md)
- [altFINS Partners with CoinEx to Connect Analytics with Trade Execution](https://longbridge.com/en/news/285067798.md)
- [Share Buyback Transaction Details April 23 – May 4, 2026 | WTKWY Stock News](https://longbridge.com/en/news/285170304.md)
- [TIC Solutions to Host and Webcast 2026 Investor Day on May 19, 2026 | TIC Stock News](https://longbridge.com/en/news/285364752.md)
- [CVS HEALTH CORPORATION REPORTS STRONG FIRST QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE | CVS Stock News](https://longbridge.com/en/news/285356226.md)